GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate ...

Retrieved on: 2021-03-08 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate .... View article details on hiswai:

Excerpt

BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused ...

Article found on: www.prnewswire.com